Business
SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Lucerne [Switzerland]/New Delhi [India], October 13: The SPARX Global Randomized Controlled Trial (RCT) has been officially initiated, marking the launch of the multinational randomized trial evaluating a drug-coated balloon (DCB)-first strategy against…
More from Business
Canada to lead largest trade delegation to India in over 30 years, CEPA talks in focus
Canada is leading its largest trade delegation to India in more than 30 years, with nearly 300 business delegates set to explore…
IMF sounds alarm on mounting fiscal strains as major economies grapple with high debt
Major economies face growing pressure to rein in fiscal deficits and rebuild financial buffers as high public debt and rising borrowing costs…
IMF projects India’s growth at 7% in FY27 and FY28, flags fragile global outlook
The International Monetary Fund (IMF) has projected India's economy to grow by 7 per cent in both FY27 and FY28, even as…
Rupee recovery needs tax reforms, stronger foreign capital inflows: SBI Research
SBI Research has called for changes in equity taxation, greater clarity on tax rules for external commercial borrowings (ECBs) and faster repatriation…
Meta unveils Muse Wonder AI models to advance ‘personal superintelligence’ push
Meta has introduced two new artificial intelligence models, Muse Wonder and Muse Wonder Full, as it advances its push towards personal superintelligence,…
FM Nirmala Sitharaman concludes Singapore visit with focus on boosting India’s infrastructure, AI, semiconductor sectors
Finance Minister Nirmala Sitharaman's visit to Singapore has strengthened investment outreach to global institutional investors, with discussions focusing on mobilising long-term capital…